Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04893265 · ClinicalTrials.gov registry record · NA
Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination
A NA study of Educational Activities, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
- 3
- Study locations
NCT04893265: Completed NA study of Educational Activities, sponsored by University of California, San Francisco.
NCT04893265 is a NA study of Educational Activities that has completed, run by University of California, San Francisco. The registered enrollment target is 247 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04893265, a NA study of Educational Activities, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study develops and evaluates the "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm randomized controlled trial will compare INFORMED delivered by LHW educational outreach plus Short Message Service (SMS) text messaging to SMS text with LHW support.
Primary Outcome
Decision conflict is measured by the 4-item Decision Making Conflict (SURE) test which asks whether participants: 1) know enough about benefits and harm; 2) clear about which benefits and harms matter most; 3) have enough support/advice to make a choice; and 4) feel sure about the best choice regarding getting tested for COVID-19. Each item is scored either 0 (unsure) or 1(sure). The total score ranges from 0 to 4. Higher scores indicate 'more sure,' lower scores indicate higher decisional confl
Conditions Studied
Interventions
- BEHAVIORAL Text Messaging Only
- BEHAVIORAL INFORMED
Study Locations (3)
California
- The Fresno Center - Fresno
- Chinese Community Health Resource Center - San Francisco
- Immigrant Resettlement & Cultural Center Inc - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT04893265 record still lists
NCT04893265 is an interventional study that assigns participants to a tested intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Educational Activities appearing as the primary indexed condition, and to 2 interventions - of which Text Messaging Only is the first listed.
NCT04893265 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04893265 about?
NCT04893265 is a clinical study titled "Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination". This study develops and evaluates the "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm randomized controlled trial will compare INFORMED d...
What is the current status of trial NCT04893265?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2021-09-30. Estimated completion is 2024-06-30.
What conditions does trial NCT04893265 study?
This clinical trial studies the following conditions: Educational Activities.
What interventions are being tested in trial NCT04893265?
The interventions under investigation include: Text Messaging Only (BEHAVIORAL), INFORMED (BEHAVIORAL).
Who is sponsoring clinical trial NCT04893265?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04893265 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Educational Activities
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04893265's enrollment target sits among peer trials
247 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- NCT04989803 · 247 participants · Phase 1
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- NCT05521399 · 247 participants
Heart Transplantation - Renewal
- NCT05556824 · 247 participants · Phase 2
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI